Concepedia

Publication | Closed Access

Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer

DOI

32

Citations

22

References

2018

Year

Alondra Escudero-Castellanos, Blanca Ocampo‐García, Guillermina Ferro‐Flores, Clara Santos‐Cuevas, Enrique Morales-Ávila, Myrna Luna‐Gutiérrez, Keila Isaac‐Olivé
Nuclear Medicine Communications

Abstract

The results warrant further preclinical studies to establish the Lu-radiotracer theranostic efficacy.

References

YearCitations

Page 1